Home › Funds › Vestal Point Capital, LP › COGT
Vestal Point Capital, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Vestal Point Capital, LP reported holding 475,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$15.2M, representing 0.39% of its reported portfolio and ranking #33 among its reported holdings. Vestal Point Capital, LP has disclosed COGT holdings in 4 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's COGT position evolved
Vestal Point Capital, LP first disclosed a stake in COGT in Q1 2025 at 3,000,000 shares (US$18.0M). The position peaked in Q1 2026 at 1,230,888 shares, worth US$47.4M. Across 4 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 475,000 shares valued at US$15.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.00M | $17.97M | New |
| Q2 2025 | 3.08M | $22.11M | Add |
| Q1 2026 | 1.23M | $47.38M | New |
| Q3 2026 | 475.00K | $15.21M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 51 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.96M sh · $190.74M · Q3 2026
- Fairmount Funds Management LLC 5.50M sh · $176.22M · Q3 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- Octagon Capital Advisors LP 2.35M sh · $75.25M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- ORBIMED ADVISORS LLC 2.00M sh · $64.16M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $52.58M · Q3 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held COGT?
Vestal Point Capital, LP has disclosed COGT holdings in 4 of the last 7 reported quarters, going back to Q1 2025.
What is Vestal Point Capital, LP's current position in COGT?
As of Q3 2026, Vestal Point Capital, LP holds 475.00K shares of COGT (COGENT BIOSCIENCES INC), valued at $15.21M, representing 0.39% of its reported portfolio and ranking #33.
Has Vestal Point Capital, LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in COGT. The position peaked in Q1 2026 at 1.23M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.